Condensed Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023	[1]
Current assets
Cash and cash equivalents	$ 79,616	$ 63,234
Short-term investments	324,897	431,011
Prepaid expenses and other current assets (Note 5)	5,518	11,257
Total current assets	410,031	505,502
Property and equipment, net (Note 4)	5,671	3,567
Operating lease right-of-use assets (Note 14)	28,054	1,211
Restricted cash	1,482	1,482
Other non-current assets	427	392
Total assets	445,665	512,154
Current liabilities
Accounts payable	6,890	4,531
Accrued research and development	23,025	12,456
Accrued liabilities (Note 6)	9,715	10,219
Operating lease liabilities, current (Note 14)	322	1,318
Total current liabilities	39,952	28,524
Operating lease liabilities, non-current (Note 14)	29,752	0
Long-term debt (Note 7)	30,139	10,054
Total liabilities	99,843	38,578
Commitments and Contingencies (Note 13)
Stockholders’ equity
Preferred stock, $0.0001 par value per share; 10,000,000 shares authorized at September 30, 2024 and December 31, 2023, and none issued or outstanding at September 30, 2024 and December 31, 2023 (Note 9)	0	0
Common stock, $0.0001 par value per share; 300,000,000 shares authorized at September 30, 2024 and December 31, 2023; and 60,849,503 and 59,921,002 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively; (Note 10)	6	6
Additional paid-in capital	1,005,288	972,973
Accumulated deficit	(660,320)	(499,748)
Accumulated other comprehensive gain	848	345
Total stockholders’ equity	345,822	473,576
Total liabilities and stockholders’ equity	$ 445,665	$ 512,154

[1] The condensed balance sheet as of December 31, 2023 has been derived from the audited financial statements as of that date.